These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29144590)

  • 1. Metabolic profiling of normal hepatocyte and hepatocellular carcinoma cells via
    Chen Y; Chen Z; Feng JH; Chen YB; Liao NS; Su Y; Zou CY
    Cell Biol Int; 2018 Apr; 42(4):425-434. PubMed ID: 29144590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revealing Different Lung Metastatic Potentials Induced Metabolic Alterations of Hepatocellular Carcinoma Cells via Proton Nuclear Magnetic Resonance Spectroscopy.
    Chen Y; Lin D; Chen Z; Feng J; Liao N
    J Cancer; 2018; 9(24):4696-4705. PubMed ID: 30588254
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma metabolomic analysis of human hepatocellular carcinoma: Diagnostic and therapeutic study.
    Chen Y; Zhou J; Li J; Feng J; Chen Z; Wang X
    Oncotarget; 2016 Jul; 7(30):47332-47342. PubMed ID: 27322079
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Gao L; Wang KX; Zhang NN; Li JQ; Qin XM; Wang XL
    J Proteome Res; 2018 May; 17(5):1833-1843. PubMed ID: 29589762
    [No Abstract]   [Full Text] [Related]  

  • 5. The aspartate metabolism pathway is differentiable in human hepatocellular carcinoma: transcriptomics and (13) C-isotope based metabolomics.
    Darpolor MM; Basu SS; Worth A; Nelson DS; Clarke-Katzenberg RH; Glickson JD; Kaplan DE; Blair IA
    NMR Biomed; 2014 Apr; 27(4):381-9. PubMed ID: 24497316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Metabolomic Profiling of Hepatocellular Carcinoma Cells Treated with Sorafenib Monotherapy vs. Sorafenib-Everolimus Combination Therapy.
    Zheng JF; Lu J; Wang XZ; Guo WH; Zhang JX
    Med Sci Monit; 2015 Jun; 21():1781-91. PubMed ID: 26092946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
    Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
    Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (1)H-NMR-based metabolomics of tumor tissue for the metabolic characterization of rat hepatocellular carcinoma formation and metastasis.
    Wang J; Zhang S; Li Z; Yang J; Huang C; Liang R; Liu Z; Zhou R
    Tumour Biol; 2011 Feb; 32(1):223-31. PubMed ID: 20890798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic and transcriptomic profiling of hepatocellular carcinomas in Hras12V transgenic mice.
    Fan T; Rong Z; Dong J; Li J; Wang K; Wang X; Li H; Chen J; Wang F; Wang J; Wang A
    Cancer Med; 2017 Oct; 6(10):2370-2384. PubMed ID: 28941178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the Potential Metabolic Pathways Involved in the Hepatic Tumorigenesis of Rat Diethylnitrosamine-Induced Hepatocellular Carcinoma via
    Chen M; Lu S; Zheng H; Xu M; Song J; Yang W; Weng Q; Zheng L; Fan X; Cheng X; Gao H; Ji J
    Biomed Res Int; 2019; 2019():9367082. PubMed ID: 30719453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of resveratrol on HepG2 cells as revealed by (1)H-NMR based metabolic profiling.
    Massimi M; Tomassini A; Sciubba F; Sobolev AP; Devirgiliis LC; Miccheli A
    Biochim Biophys Acta; 2012 Jan; 1820(1):1-8. PubMed ID: 22037246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR-based metabolic profiling of human hepatoma cells in relation to cell growth by culture media analysis.
    Miccheli AT; Miccheli A; Di Clemente R; Valerio M; Coluccia P; Bizzarri M; Conti F
    Biochim Biophys Acta; 2006 Nov; 1760(11):1723-31. PubMed ID: 17052856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global Metabolic Profiling Identifies a Pivotal Role of Proline and Hydroxyproline Metabolism in Supporting Hypoxic Response in Hepatocellular Carcinoma.
    Tang L; Zeng J; Geng P; Fang C; Wang Y; Sun M; Wang C; Wang J; Yin P; Hu C; Guo L; Yu J; Gao P; Li E; Zhuang Z; Xu G; Liu Y
    Clin Cancer Res; 2018 Jan; 24(2):474-485. PubMed ID: 29084919
    [No Abstract]   [Full Text] [Related]  

  • 14. 1H-NMR-based metabolomics reveals the biomarker panel and molecular mechanism of hepatocellular carcinoma progression.
    Wang KX; Du GH; Qin XM; Gao L
    Anal Bioanal Chem; 2022 Feb; 414(4):1525-1537. PubMed ID: 35024914
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Jinks M; Davies EC; Boughton BA; Lodge S; Maker GL
    Toxicol In Vitro; 2024 Aug; 99():105881. PubMed ID: 38906200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic fingerprinting by nuclear magnetic resonance of hepatocellular carcinoma cells during p53 reactivation-induced senescence.
    Knopf P; Pacheco-Torres J; Zizmare L; Mori N; Wildes F; Zhou B; Krishnamachary B; Mironchik Y; Kneilling M; Trautwein C; Pichler BJ; Bhujwalla ZM
    NMR Biomed; 2024 Sep; 37(9):e5157. PubMed ID: 38589764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global changes to HepG2 cell metabolism in response to galactose treatment.
    Skolik RA; Solocinski J; Konkle ME; Chakraborty N; Menze MA
    Am J Physiol Cell Physiol; 2021 May; 320(5):C778-C793. PubMed ID: 33439775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Multi-Omics Study Revealing the Metabolic Effects of Estrogen in Liver Cancer Cells HepG2.
    Shen M; Xu M; Zhong F; Crist MC; Prior AB; Yang K; Allaire DM; Choueiry F; Zhu J; Shi H
    Cells; 2021 Feb; 10(2):. PubMed ID: 33672651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities.
    De Matteis S; Ragusa A; Marisi G; De Domenico S; Casadei Gardini A; Bonafè M; Giudetti AM
    Oxid Med Cell Longev; 2018; 2018():7512159. PubMed ID: 30524660
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.